Short Commentary on Approved Medications for COVID -19 Management?

COVID-19 Intervention Scenarios for a Long-term Disease Management

Background The first outbreak of coronavirus disease 2019 (COVID-19) was successfully restrained in many countries around the world by means of a severe lockdown. Now, we are entering the second phase of the pandemics in which the spread of the virus needs to be contained within the limits that national health systems can cope with. This second phase of the epidemics is expected to last until a...

Explanation of the Coronavirus (COVID-19) Crisis Based on Disinformation Theory: A commentary

Strategic Management of Disease Covid-19

Introduction: Following the outbreak of Qovid-19, many studies have been published rapidly on research sites and scientific literature around the world. This study aimed to investigate the strategies of this epidemic. This study was conducted in a structured review method without statistical analysis that was conducted by searching related studies and resources in databases of Web of Science an...

COVID-19 in Nursing Homes: The Problematic Management of Residents Without Positive COVID-19 RT-PCR

FDA-approved medications that impair human spermatogenesis

We herein provide an overview of the single-ingredient U.S. Food and Drug Administration (FDA)-approved drugs that affect human spermatogenesis, potentially resulting in a negative impact on male fertility. To provide this information, we performed an in-depth search of DailyMed, the official website for FDA-approved drug labels. Not surprisingly, hormone-based agents were found to be the drugs...